The life sciences technology company has taken its funding past the $15m mark with mutual insurance firm Sham co-leading the round.
France-based cellular diagnostics company Cytoo secured €7m ($10m) in a series C round co-led by medical risk management company Sham and venture capital (VC) fund the Entrepreneur’s Fund on Saturday. VC firm Auriga Partners and Cytoo co-founder Jacques Lewiner also participated.
Auriga Partners led Cytoo’s $4.7m series B round, in 2009, which followed a $700,000 seed round raised the year backed by CEA Valorisation, the investment subsidiary of the French government backed Atomic Energy and Alternative energies Commission, as well…
